OpenAI· @OpenAI · X·· 3 小时前AI 评分55
AI 导读
OpenAI 宣布收购 Orchestra Bio，一个帮助生物制药团队协调复杂药物研发流程的平台。双方将基于 OpenAI 面向生命科学研究的 AI 模型与工具 Rosalind 展开建设，简化相关运营，帮助新疗法更快惠及患者，并欢迎 Ashok Raj 及其团队加入。
正文 · 原文
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
来源：OpenAI · x.com